Literature DB >> 6250575

Proteolytic cleavage of methionyl transfer ribonucleic acid synthetase from Bacillus stearothermophilus: effects on activity and structure.

T Kalogerakos, P Dessen, G Fayat, S Blanquet.   

Abstract

Methionyl-tRNA synthetase from Bacillus stearothermophilus, a dimer of molecular weight 2 X 85K, is converted by limited subtilisin digestion into a fully active monomeric fragment of molecular weight 64K. The reversible methionine activation reaction of these enzymes was followed through the variation of the intensity of their trypotophan fluorescence. Equilibrium and stopped-flow experiments show that the rate and mechanism for adenylate formation supported by the monomeric derivative are undistinguishable from those of each adenylating site of the native dimeric enzyme. In contrast, the rate of tRNA aminoacylation is improved upon limited proteolysis of the native enzyme. This behavior can be related to the anticooperativity of the binding of tRNA molecules to native dimeric enzyme. Accordingly, at 25 degrees C, the dimer might behave as a half-of-the-sites enzyme with only one active tRNA site at a time, compared to two after limited proteolysis with consequent irreversible disociation into two 64K fragments. Another modified form of the enzyme is obtained through limited tryptic digestion. This derivative is completely devoid of activity although its molecular weight under nondenaturating conditions remains undistinguishable from that of the 64K fragment generated by subtilisin. Denaturation reveals that this tryptic derivative is composed of two subfragments with molecular weights of 33K and 29K, respectively. The same fragments may also be directly obtained through limited tryptic digestion of the subtilsic fragment. Interestingly, although trypsin treatment has abolished the activity of the enzyme, fluorescence studies demonstrate that the ATP and methionine binding sites have remained intact. It is shown that the effect of the internal cut made by trypsin into the active 64K fragment has been to considerably depress the "coupling" between the methionine and nucleotide binding sites. Finally, the rate of inactivation of the enzyme by trypsin is observed to be substantially decreased by in situ synthetized methionyl adenylate but not by tRNA. These properties and others are discussed in relation to the problem of its significance of repeating sequences and structural "domains" within the class of aminoacyl-tRNA synthetases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250575     DOI: 10.1021/bi00557a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Inhibition of methionyl-tRNA synthetase by REP8839 and effects of resistance mutations on enzyme activity.

Authors:  Louis S Green; James M Bullard; Wendy Ribble; Frank Dean; David F Ayers; Urs A Ochsner; Nebojsa Janjic; Thale C Jarvis
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

2.  Methionyl-tRNA synthetase from Bacillus stearothermophilus: structural and functional identities with the Escherichia coli enzyme.

Authors:  Y Mechulam; E Schmitt; M Panvert; J M Schmitter; M Lapadat-Tapolsky; T Meinnel; P Dessen; S Blanquet; G Fayat
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

3.  Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.

Authors:  Leah S Torrie; Stephen Brand; David A Robinson; Eun Jung Ko; Laste Stojanovski; Frederick R C Simeons; Susan Wyllie; John Thomas; Lucy Ellis; Maria Osuna-Cabello; Ola Epemolu; Andrea Nühs; Jennifer Riley; Lorna MacLean; Sujatha Manthri; Kevin D Read; Ian H Gilbert; Alan H Fairlamb; Manu De Rycker
Journal:  ACS Infect Dis       Date:  2017-10-02       Impact factor: 5.084

4.  Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism.

Authors:  Wei Wang; Bo Qin; Justyna Aleksandra Wojdyla; Meitian Wang; Xiaopan Gao; Sheng Cui
Journal:  IUCrJ       Date:  2018-06-22       Impact factor: 4.769

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.